Mindray CL-900i assay: An effective assay for hepatitis B surface antigen screening with superior specificity
Mindray CL-900i could offer a cost-effective alternative for HBsAg screening, boasting perfect specificity and overcoming the limitations of current automated assays.
Authors
- Laith Jamal Abu-Raddad (ORCID: https://orcid.org/0000-0003-0790-0506)
- Gheyath K. Nasrallah (ORCID: https://orcid.org/0000-0001-9252-1038)
- Mutaz Mohamed Ali
- Ibrahim Al Shaar
- Dayana El Chaar
- Parveen Banu Nizamuddin (ORCID: https://orcid.org/0009-0000-9695-1422)
- Salma Younes (ORCID: https://orcid.org/0000-0002-2453-5953)
- Palanee Ammaranond (ORCID: https://orcid.org/0000-0003-4958-9058)
- Mazen Najib Abouassali
- Ibrahim Wissam Karimeh
- Maryam A Alabdulmalek
- Ahmed Ismail
- Zhu Louyin
- Nadin Younes (ORCID: https://orcid.org/0000-0002-5241-944X)
- Mohammed Abdelfatah Ibrahim
- Manal Elshaikh
- Khadija N. Mohammad
Institutions
- Chulalongkorn University (TH)
- Cornell University (US)
- Ministry of Public Health (QA)
- Weill Cornell Medical College in Qatar (QA)
- Mindray (China) (CN)
- Qatar University (QA)
Publication Details
- Journal
- IJID Regions
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1016/j.ijregi.2024.100561
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Qatar Foundation
- Fonds National de la Recherche Luxembourg
- Qatar National Research Fund